Merck KGaA (OTCMKTS:MKKGY) Sees Significant Drop in Short Interest

Merck KGaA (OTCMKTS:MKKGY) saw a large drop in short interest in March. As of March 15th, there was short interest totalling 900 shares, a drop of 88.9% from the February 28th total of 8,100 shares. Based on an average trading volume of 129,800 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.

Merck KGaA Stock Performance

Shares of OTCMKTS MKKGY traded down $1.03 during trading on Wednesday, reaching $27.23. The stock had a trading volume of 47,833 shares, compared to its average volume of 126,469. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.91 and a current ratio of 1.33. The stock has a market cap of $17.60 billion, a PE ratio of 16.81, a P/E/G ratio of 2.05 and a beta of 0.98. Merck KGaA has a one year low of $27.19 and a one year high of $39.17. The firm’s 50 day moving average price is $29.18 and its two-hundred day moving average price is $31.07.

Merck KGaA (OTCMKTS:MKKGY) last released its earnings results on Thursday, March 6th. The company reported $0.54 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.07. Merck KGaA had a net margin of 12.89% and a return on equity of 10.41%. The firm had revenue of $5.78 billion during the quarter, compared to analyst estimates of $5.40 billion. On average, research analysts forecast that Merck KGaA will post 1.87 earnings per share for the current fiscal year.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.